Literature DB >> 21640813

Cytotoxicity of Triptolide and Triptolide loaded polymeric micelles in vitro.

Shunzhen Zheng1, Karin Löw, Sylvia Wagner, Xiangliang Yang, Hagen von Briesen, Shengquan Zou.   

Abstract

Triptolide (TP), a diterpenoid triepoxide purified from the Chinese herb Tripterygium wilfordii Hook F is characterized by strong anti-tumor effects on various cancer cells. Except its anti-tumor effects, TP also shows multiple pharmacological side activities, such as anti-inflammatory, immune-suppressive and male anti-fertility. In order to reduce these side effects, especially the immuno-suppressive activity when used to cure cancer, a novel polymeric micelle system containing TP (TP-PM) was constructed. The immune-modulation effects of TP-PM have been evaluated by previous studies. In this study, we compared the cytotoxicity of TP and TP-PM on Jurkat and HT29 cells. Therefore, we determined the cell viability, membrane integrity, cell proliferation, apoptosis, and caspase 3/7 activity after exposure to TP and TP-PM. The results demonstrated that actually low concentrated TP and TP-PM could induce an inhibition of cell growth and proliferation as well as membrane damage in both tumor cell lines. TP and TP-PM induced apoptosis and caused activation of caspase 3/7 even at low concentrations. Both formulations destroyed the membrane of Jurkat cells, nevertheless, TP-PM showed stronger pernicious effects. In general, TP-PM induced in both tested cell lines stronger effects than TP. Therefore, polymeric micelles can be considered as promising carriers for TP in cancer therapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640813     DOI: 10.1016/j.tiv.2011.05.020

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  3 in total

1.  The potential of follicle-stimulating hormone peptide-modified triptolide-loaded nanoparticles to induce a mouse model of premature ovarian insufficiency.

Authors:  Xiu-Ying Chen; Wu-Lian Chen; Min Ma; Chao Gu; Xi-Rong Xiao; Bin Li
Journal:  Int J Nanomedicine       Date:  2015-04-07

2.  Triptolide, a HSP90 middle domain inhibitor, induces apoptosis in triple manner.

Authors:  Frederick Zhehao Zhang; Derek Hoi-Hang Ho; Roger Hoi-Fung Wong
Journal:  Oncotarget       Date:  2018-04-27

Review 3.  Delivery of triptolide: a combination of traditional Chinese medicine and nanomedicine.

Authors:  Rui Sun; Jingyue Dai; Mingjian Ling; Ling Yu; Zhiqiang Yu; Longguang Tang
Journal:  J Nanobiotechnology       Date:  2022-04-20       Impact factor: 9.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.